We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

ARTES and Boehringer Ingelheim Animal Health Announce Collaboration

News   Mar 17, 2015

 
ARTES and Boehringer Ingelheim Animal Health Announce Collaboration
 
 
Advertisement
 

RELATED ARTICLES

Using Viruses To Train the Immune System To Tackle Tumors

News

A research group has developed a strategy that is being tested in clinical studies for therapeutic cancer vaccines. Using two different viruses as vehicles, they administered specific tumor components in mice with cancer in order to stimulate their immune system to attack the tumor.

READ MORE

A New Nanotechnology-Based COVID-19 Vaccine Candidate

News

Researchers from Cleveland Clinic’s Global Center for Human Health & Pathogen Research have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.

READ MORE

Janssen COVID-19 Vaccine Issued Emergency Use Authorization by the FDA

News

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE